Laboratory Findings on Admission
Compared with non-critical patients, the inflammatory biomarkers in
critical patients including c-reactive protein (CRP), procalcitonin
(PCT), interleukin-2 receptor (IL-2R), α-tumor necrosis factor (TNF-A)
and Interleukin-6 (IL-6) were significantly higher (p <0.05). The
cardiac biomarkers in critical patients including creatine kinase MB
(CK-MB), high-sensitivity troponin I (hs-cTnI), creatine kinase (CK),
lactate dehydrogenase (LDH), α - hydroxybutyrate dehydrogenase (HBDH)
and brain natriuretic peptide (BNP) were significantly higher than
non-critical patients (p <0.001). There were numerous differences
in other baseline laboratory findings between two groups, including
longer prothrombin time, higher levels of D-dimer and aspartate
aminotransferase (AST) (Table 3).